Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review-Reference-Cited by-同舟云学术

Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review

Published:2018-08 Issue:3 Volume:1 Page:223-230
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Lotan Yair,Black Peter C.,Caba Laura,Chang Sam S.,Cookson Michael S.,Daneshmand Siamak,Kamat Ashish M.,McKiernan James M.,Pruthi Raj S.,Ritch Chad R.,Steinberg Gary D.,Svatek Robert S.,Zwarthoff Ellen C.

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference32 articles.

1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017

2. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017

3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

4. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta–T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus Calmette-Guérin;Cambier;Eur Urol,2016

5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Elusive Horizon: Biomarkers in Urothelial Carcinoma;European Urology;2024-04

2. Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?;Cancers;2023-07-19

3. Urine biomarkers in bladder cancer — current status and future perspectives;Nature Reviews Urology;2023-05-24

4. A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines;European Urology Oncology;2023-04

5. A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells;Genes & Diseases;2022-11